Journal: Cell Reports Medicine
Article Title: Multi-modal analysis reveals tumor and immune features distinguishing EBV-positive and EBV-negative post-transplant lymphoproliferative disorders
doi: 10.1016/j.xcrm.2024.101851
Figure Lengend Snippet:
Article Snippet: Heavy metal-tagged antibodies were purchased pre-conjugated from Fluidigm where available, or conjugated and validated in-house using the Maxpar X8 Antibody Labeling Kits (Fluidigm) or the MIBItag Conjugation Kits (IonPath) according to the manufacturer’s instructions.
Techniques: Recombinant, cDNA Synthesis, SYBR Green Assay, Blocking Assay, Cell Stimulation, Staining, Electron Microscopy, Conjugation Assay, Antibody Labeling, Gene Knockout, DNA Extraction, Enzyme-linked Immunosorbent Assay, CyQUANT Assay, Proliferation Assay, Gene Expression, Microarray, Software